Efficacy, safety, and prognosis prediction in patients treated with ribociclib in combination with letrozole: Final results of phase 3b RIBECCA study in hormone receptor positive, human epidermal growth factor receptor-2 negative, locally advanced or metastatic breast cancer
-
Published:2024-02
Issue:
Volume:198
Page:113480
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Fasching Peter A.,
Decker Thomas,
Hartkopf AndreasORCID,
Nusch Arnd,
Heinrich Bernhard J.,
Kurbacher Christian,
Fuchs Roswitha,
Tesch Hans,
Krabisch Petra,
Huober Jens,
Kuemmel Sherko,
Brucker SaraORCID,
Janni Wolfgang,
Schneeweiss Andreas,
Schuler MartinORCID,
Fehm Tanja,
Lüftner Diana,
Quiering Claudia,
Voges Claudia,
Kreuzeder Julia,
Reinisch MatteaORCID
Subject
Cancer Research,Oncology